Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Idea to Innovation

University of Saskatchewan

$10,000.00

Proposal for market assessment and feasibility study on cyclic peptide extracts for the companion animal feed market

EF 2013-14

Résumé
This technology pertains to biological effects observed in vivo and in vitro of a cyclic peptide extract obtained from flax oil. This extract may have major appeal in both animal and human health markets as natural health products, as there are demonstrated indications of anti-inflammatory, anti-parasitic and anti-microbial activity. The University of Saskatchewan Industry Liaison Office (ILO) has completed a preliminary assessment and concluded there is protectable intellectual property and that there are promising commercialization opportunities in the companion animal natural health products market. This proposal is for a Market Assessment Plan to be performed by the ILO. The outcome of this market assessment study will be the foundation for a commercialization strategy, (license to an existing company or create a start-up company?). The study will also provide assistance in product development by supplying information on what attributes would improve the marketability of the end product (unique benefits, novel modes of action) and identify potential manufacturing and other commercialization partners in the nutraceutical companion animal markets and the animal feed industry. The researchers will apply for NSERC I2I Phase 1 funding to complete the comprehensive efficacy and toxicological studies for the biologically active materials. Availability of a market study is a requirement for this application to NSERC I2I.
Programme
Idea to Innovation
Emplacement
Saskatchewan, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
446982-2013
Name nom
Laarveld, Bernard
Department département
Animal and Poultry Science
Organization id
16
Institution établissement
University of Saskatchewan
Province en
Saskatchewan
Province fr
Saskatchewan
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2013
Award amount
10000
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
102
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal management (animal diseases, breeding)
Area of application fr
Gestion des animaux (maladies animales, reproduction)
Research subject code
5512
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Veterinary sciences
Research subject fr
Médecine vétérinaire
Partie
1
Nb partie
1
Application title
Proposal for market assessment and feasibility study on cyclic peptide extracts for the companion animal feed market
Keyword
NSERC
Application summary
This technology pertains to biological effects observed in vivo and in vitro of a cyclic peptide extract obtained from flax oil. This extract may have major appeal in both animal and human health markets as natural health products, as there are demonstrated indications of anti-inflammatory, anti-parasitic and anti-microbial activity. The University of Saskatchewan Industry Liaison Office (ILO) has completed a preliminary assessment and concluded there is protectable intellectual property and that there are promising commercialization opportunities in the companion animal natural health products market. This proposal is for a Market Assessment Plan to be performed by the ILO. The outcome of this market assessment study will be the foundation for a commercialization strategy, (license to an existing company or create a start-up company?). The study will also provide assistance in product development by supplying information on what attributes would improve the marketability of the end product (unique benefits, novel modes of action) and identify potential manufacturing and other commercialization partners in the nutraceutical companion animal markets and the animal feed industry. The researchers will apply for NSERC I2I Phase 1 funding to complete the comprehensive efficacy and toxicological studies for the biologically active materials. Availability of a market study is a requirement for this application to NSERC I2I.